劉 嘉仁

Medicine & Life Sciences

1. Taiwan 100%
2. Population 84%
3. Atrial Fibrillation 79%
4. Cohort Studies 69%
5. Multiple Myeloma 51%
6. Stroke 45%
7. Hematopoietic Stem Cell Transplantation 40%
8. National Health Programs 38%
9. Neoplasms 35%
10. Mortality 29%
11. Tuberculosis 26%
12. Second Primary Neoplasms 24%
13. Survival 22%
14. Databases 22%
15. Comorbidity 19%
16. Graft vs Host Disease 18%
17. Transplants 16%
18. Bipolar Disorder 16%
19. Chronic Obstructive Pulmonary Disease 15%
20. Infections 13%
21. Drug Therapy 12%
22. Systemic Scleroderma 12%
23. Liver Abscess 11%
24. Sleep Apnea Syndromes 11%
25. Retrospective Studies 11%
26. Depressive Disorder 11%
27. Leukemia 11%
28. Case-Control Studies 11%
29. Radiotherapy 11%
30. Therapeutics 10%
31. Hematopoietic Stem Cells 10%
32. Systemic Lupus Erythematosus 10%
33. Myocardial Infarction 9%
34. Bortezomib 9%
35. Anticoagulants 9%
36. Stomach Neoplasms 9%
37. Colorectal Neoplasms 9%
38. Transplant Recipients 9%
39. Hepatocellular Carcinoma 8%
40. Heart Failure 8%
41. Dental Scaling 8%
42. Bone Marrow 8%
43. Pyogenic Liver Abscess 8%
44. Chronic Kidney Failure 7%
45. Hydroxymethylglutaryl-CoA Reductase Inhibitors 7%